RONGCHANG PHARMACEUTICALS, LTD

2023

Rongchang Pharmaceuticals established its small-molecule targeted innovative drug division, focusing on disease areas with significant unmet clinical needs such as oncology.

2020

A corporate restructuring was completed, with RemeGen and Mabplex spun off from Rongchang Pharmaceuticals, forming a new business structure.

2017

The company partnered with the Yantai Economic and Technological Development Zone to establish the Yantai YEDA International Incubator for Biomedical Innovation Co., Ltd. The same year, Rongchang Pharmaceuticals secured 1.25 billion yuan in its second equity financing round.

2013

MabPlex International Co. Ltd. was established.

2010

Rongchang Pharmaceuticals acquired Shandong Lutai Huanzhong Pharmaceuticals Co., Ltd., later renamed Rongchang Pharmaceuticals (Zibo) Co., Ltd.

2009

The company completed its first financing round, raising nearly 100 million yuan.

2008

Rongchang Pharmaceuticals co-founded Yantai Rongchang Bioengineering Co., Ltd. with Dr. Jianmin Fang, later renamed Rongchang Biopharma (Yantai) Co., Ltd.

2005

Endostar, the world’s first "vascular endothelial inhibitor" anticancer drug, was approved for market launch by the NMPA.

2001

The National Medical Products Administration (NMPA) approved "YH-16" (Endostar) for Phase I clinical trials, marking China’s first anti-angiogenic Class 1 biopharmaceutical to enter clinical research.

1998

Rongchang Pharmaceuticals passed the GMP certification inspection by China's Ministry of Health in a single review, becoming the first TCM company to obtain GMP certification in Shandong province.

1996

The company entered the biopharmaceutical field, collaborating with Fudan University to develop recombinant human nerve growth factor (NGF).

1995

By advertising during prime time on CCTV, Rongchang Pharmaceuticals achieved an annual output value of 106 million yuan.

1994

The company launched its first product, "Rongchang Gangtai," later upgraded to "Gangtai," which was classified as a national confidential traditional Chinese medicine formula.

1993

March 18, 1993: Yantai Rongchang Pharmaceuticals Co., Ltd. was officially registered and established.